FDA Reverses Peptide Ban: BPC 157, GHK Cu Back! This is monumental news for advanced wellness. The FDA has restored BPC 157, GHK Cu, and 12 other crucial peptides to legal compounding status, effective 2026 When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Bpc 157 Fda Status Or Approved Or Banned BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn